Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients-Reference-Cited by-全球学者库

Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients

Published:2019-06-04 Issue:23 Volume:139 Page:2628-2638
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Jukema J. Wouter¹,Timal Rohit J.¹,Rotmans Joris I.²,Hensen Liselotte C. R.¹,Buiten Maurits S.¹,de Bie Mihaly K.¹,Putter Hein³,Zwinderman Aeilko H.⁴,van Erven Lieselot¹,Krol-van Straaten M. Jacqueline⁵,Hommes Nienke⁶,Gabreëls Bas⁷,van Dorp Wim⁸,van Dam Bastiaan⁹,Herzog Charles A.¹⁰,Schalij Martin J.¹,Rabelink Ton J.²,

Affiliation:

1. Department of Cardiology (J.W.J., R.J.T., L.C.R.H., M.S.B., M.K.d.B., L.v.E., M.J.S.), Leiden University Medical Center, The Netherlands.

2. Department of Internal Medicine (J.I.R., T.J.R.), Leiden University Medical Center, The Netherlands.

3. Department of Biomedical Data Sciences (H.P.), Leiden University Medical Center, The Netherlands.

4. Department of Medical Statistics, Academic Medical Center, Amsterdam, The Netherlands (A.H.Z.).

5. Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands (M.J.K.v.S.).

6. Department of Internal Medicine, Haaglanden Medisch Centrum, The Hague, The Netherlands (N.H.).

7. Department of Internal Medicine, Alrijne Ziekenhuis, Leiderdorp, The Netherlands (B.G.).

8. Department of Internal Medicine, Spaarne Gasthuis, Haarlem, The Netherlands (W.v.D.).

9. Department of Internal Medicine, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands (B.v.D.).

10. Department of Internal Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis (C.A.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference33 articles.

1. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States

2. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

3. The current status of interventions aiming at reducing sudden cardiac death in dialysis patients

4. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC).;Priori SG;EP Europace,2015

5. Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated Glomerular Filtration Rate and Implantable Cardioverter‐Defibrillator in Nonischemic Systolic Heart Failure: Extended Follow‐Up of DANISH;Journal of the American Heart Association;2024-01-31

2. Cardiac Device Therapy in Patients with Chronic Kidney Disease: An Update;Journal of Clinical Medicine;2024-01-17

3. Chronic kidney disease associated cardiomyopathy: recent advances and future perspectives;Current Opinion in Nephrology & Hypertension;2024-01-05

4. Personalizing electrolytes in the dialysis prescription: what, why and how?;Clinical Kidney Journal;2023-10-13

5. One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk;Journal of Clinical Medicine;2023-08-30